Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and safety of Neurodoron in patients with nervous exhaustion
2010-024189-23Phase 4Completed
- Sponsor
- Weleda
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in asthenia comparing Neurodoron with Placebo (2 arms). Primary endpoints: Reduction in exhaustion symptoms (primary, sequential), Exhaustion symptoms sumscore and 2 more. Started Apr 2011; status: completed.
02
Drugs
Neurodoron
03
Conditions
asthenia
Beyond the preview
Go deeper on 2010-024189-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024189-23.